///Platelet Rich Plasma (PRP) Market Growth, Future Prospects & Competitive

Platelet Rich Plasma (PRP) Market Growth, Future Prospects & Competitive

Date: January, 2016

Platelet rich plasma (PRP) is a product that contains large number of platelets in a small plasma volume. PRP works as a fibrin tissue adhesive with tissue sealing and hemostatic characteristics. PRP differs from platelet-poor tissue and fibrin glue because PRP provides a unique ability to augment wound healing process and osteogenesis. PRP functions as a safe, biocompatible prompt hemostatic agent and fast-tracks epidermal, epithelial and endothelial regeneration. PRP enhances collagen synthesis, encourages angiogenesis, reduces dermal scarring, augments soft tissue healing and reverses inhibition of glucocorticoid would healing. High concentration of leukocyte in PRP offers additional antimicrobial effect.
PRP offers a wide range of clinical healing uses in otolaryngology, general surgery, cosmetic surgery and aesthetics, burn and would healing, cardiovascular surgery, oral and maxillofacial surgical procedures and others. PRP has proven effectiveness in treating chronic non-healing wounds and has been adopted as antiangiogenic agent. In surgical procedures, PRP reduces the risk of postoperative and preoperative bleeding both at donor and recipient sites; it augments soft tissue healing and facilitates stability to grafted tissue at recipient site owing to its adhesive and cohesive properties.
The global platelet rich plasma market is segmented on the following bases:

1. Type

a. Pure-Platelet Rich Plasma (P-PRP)
b. Leukocyte-Platelet Rich Plasma (L-PRP)
c. Leukocyte-Platelet Rich Fibrin (L-PRF)

2. Origin

a. Allogeneic
b. Autologous
c. Homologous

3. Clinical Applications

a. General Surgery
b. Neurosurgery
c. Cosmetic Surgery and Aesthetics
d. Orthopedic and Spinal Surgery
e. Others (Otorhinolaryngology-Head and Neck Surgery, Oral and Maxillofacial Surgery, Periodontal Surgery, Urology, Cardiothoracic Surgery, etc.)

4. Geography

a. North America

i. US
ii. Canada

b. Europe

i. UK
ii. Germany
iii. Rest of Europe

c. Asia Pacific

i. Japan
ii. China
iii. Rest of APAC
d. Latin America
e. Middle East and Africa

Key players identified for platelet rich plasma market include but are not limited to:

Arthrex, Inc., Arteriocyte Medical Systems, Inc., DePuy Synthes, Inc., Biomet, Inc., Cesca Therapeutics, Inc., Dr. PRP America LLC., EmCyte Corporation, AdiStem Ltd., Exactech, Inc., Nuo Therapeutics, Inc., Regen Lab SA, Harvest Technologies Corp. and several others

This report offers:

  • An overview of the global markets for platelet rich plasma
  • Market trends assessment for the period 2013-2023, with historical information for 2013 & 2014, and projections through 2023, with respective CAGRS during 2016-2023
  • Qualitative assessment tools such as market drivers, challenges and future prospects, major commercial events, etc.
  • Market competition scrutiny tools such as market share assessment, attractive investment proposition and others
  • Focus on each level of market segmentation based on product approvals, launch, and current and anticipated market dynamics
  • A general overview of the industry structure
  • Company profiles highlighting key information about the major players operating in the platelet rich plasma market


PRP means Platelet Rich Plasma. The Plasma liquid in the blood includes red and white blood cells and platelets. Platelets form 10% of the plasma and in the concept of PRP, the platelet ratio is flipped to 90%. It is given in the form of an injection to patients looking to treat tissue damages, skin issues etc.
A non-surgical therapy in nature, PRP is used for healing in several medicine fields including sports medicines and orthopedics. PRP is nothing but the patient’s own blood which is administered in a way such that the healing components (growth factors) present in the platelets are released, thus fuelling fast recovery.
PRP is majorly useful in cases of soft tissue injuries, including ligament sprains, muscle pulls / tears, tendon tears, tendonitis and tendinosis. It has been an effective way to treat cartilage degeneration like arthritis as well.
With its methodology, PRP is developed to heal the injured region through the initiation of growth factors in your platelets. It is a cure and not just a temporary solution to limit any injury.
In most cases, the procedure can be well tolerated by patients but there may be soreness after the injection as PRP induces


1340 Tully Rd #314
San Jose, CA 95122



New client pricing-

2 kits for $49!


Want to get in touch? Please do, we’d love to hear from you.

For general inquiries, you can fill out and submit your contact information. We also encourage you to call our offices directly at 866.704.8572 for the most current information.